All Type of News
M&As looming larger in pharmaceutical industry
The government’s plan to cut domestic drug prices by an average of 14 percent will make it harder for companies to do business in the pharmaceutical market.
Analysts expect a large number of mergers and acquisition...
Health insurance fee to rise 2.8%
The Ministry of Health and Welfare said Wednesday it will raise health insurance premiums by 2.8 percent beginning next year. Under the ministry's plan, individual subscribers and workplace subscribers must pay an add...
Government to increase hospital treatment fee by 1.7%
The government said on November 15 that it will increase the medical fee at hospital by 1.7 percent in 2012, according to Ministry of Health and Welfare.
A ministry spokesperson said the hike was inevitable because...
Government urged to take bolder steps to rid medical sector of corrupt practices
It has long been a tough challenge for health authorities to break corrupt ties between drug makers, doctors and pharmacists.
Unfortunately, however, there are still many medical professionals who do not feel compu...
Drug export gains momentum in September
Korea’s drug exports showed a positive sign in September, while its producer’s shipment index declined.
The drug export shipment was 258.0 in September, up 14.9 percent from the same month of last year.
The cou...
Mvix is effective in once daily dosing for erectile dysfunction/positive BPH results
SK Chemicals announced that it has completed a 140 patient once-a-day dosing clinical study of mirodenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED).
A total of 1...
Concerns growing over cash incentive plan
There are mounting concerns over the whereabouts of the contentious cash incentive system, which took effect last November but was inevitably delayed for 1 year.
Still, the government shows a lukewarm attitude over...
CrystalGenomics gets U.S. patent on novel cancer candidate
CrystalGenomics, a high-flying Korean biotechnology venture, announced Friday in its regulatory filing that the U.S. Patent and Trademark Office issued the company a patent covering the investigational cancer candidat...
Pharmaceutical firms brace for specter of massive drug price cuts
Domestic drug firms are scrambling to slash their administrative and promotional expenses from the current 40 percent to 30 percent, as they are expected to face serious financial losses starting next year with the sp...
New drug pricing reform will hurt leading pharmaceutical firms
A report released on November 11 said Korea's eight leading drug makers could lose up to 765.5 billion won in revenue and 750.8 billion won in operating income by 2014 if the government’s drug price cut plan goes into...
